Bank of Montreal
LGND icon

Bank of Montreal’s Ligand Pharmaceuticals LGND Stock Holding History

Bank of Montreal’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,175
Closed -$619K – 4251
2017
Q2 		$619K Hold
8,175
– – ﹤0.01% 2175
2017
Q1 		$540K Buy
+8,175
New +$538K ﹤0.01% 2082

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of Montreal's LGND Position: Q2 2026 in Review

Bank of Montreal reduced its Ligand Pharmaceuticals (LGND) stake by 74% in Q2 2026, selling an estimated $15M and leaving 22,318 shares worth $7.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Bank of Montreal first reported a position in LGND in Q2 2013 and has held it in 47 quarters since. The position peaked at $23.8M in Q4 2025. 255 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Bank of Montreal held 22,318 shares of Ligand Pharmaceuticals worth $7.05M as of Q2 2026.
  • Bank of Montreal sold 63,865 Ligand Pharmaceuticals shares in Q2 2026, an estimated $15M.
  • Ligand Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1264 holding.
  • Bank of Montreal first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Bank of Montreal's Ligand Pharmaceuticals position peaked at $23.8M in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.